Elevance (ELV) stock thrives with fee-based plans, preventive care, and disciplined capital management, ensuring growth and strong investor returns. See more.

Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...

In a report released today, Ryan Langston from TD Cowen maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 4.67%, which means the company has less short interest than most of its peers. Did you ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Elevance Health, Inc.

A number of equities analysts have commented on the stock. Stephens downgraded shares of Elevance Health from an “overweight” rating to an “equal weight” rating and cut their price ...

deplorable criticisms of health insurance companies and their executives. Negative and controversial headlines tend to hurt share prices. This was true of Elevance’s stock in the aftermath of ...

Wall Street expects Elevance Health to post $11.09 EPS and $45.93 billion in revenue, reflecting solid year-over-year growth.

Elevance Health’s stock has danced a bit faster than its actual financial performance over the past five years, delivering a 68% rise in share price despite a more modest 7% annual EPS growth. This ...